Company Overview - Firefly Neuroscience Inc is an AI company focused on developing innovative solutions to improve brain health outcomes for patients with neurological and mental disorders [5] - The company's FDA-cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD [5] - Firefly has built a comprehensive database of brain wave tests over 15 years, securing patent protection and achieving FDA clearance [5] - The company is now commercially launching BNA™, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use [5] Technology Innovation - Firefly's BNA™ technology platform utilizes Resting EEG and Cognitive EEG (ERP) data to assess patients' brain age, marking the first instance where cognitive data measured by ERP has been successfully utilized for assessing biological brain age [2] - The BNA™ system was developed using AI and machine learning on Firefly's extensive proprietary database of standardized, high-definition longitudinal EEGs of over 17,000 patients representing twelve disorders, as well as clinically normal patients [8] - BNA™, in conjunction with an FDA-cleared EEG system, provides clinicians with comprehensive insights into brain function, enhancing their ability to accurately diagnose mental and cognitive disorders and evaluate optimal therapies [8] Research Advancement - Firefly announced the advancement of research to assess a patient's brain age via its FDA-cleared BNA™ technology platform, potentially paving the way for a proactive and scalable approach to early screening and monitoring for Alzheimer's patients [1] - The BNA™ data assessment can identify significant disparities between brain age and chronological age, which could serve as a valuable risk factor for dementia [2] - This breakthrough underscores the company's commitment to pushing the boundaries of innovation in brain health, aiming to make a meaningful impact on patients' lives [2]
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform